Jean Ferand Armand Lacrampe

Title: **Inventor Spotlight: Jean Ferand Armand Lacrampe**

Introduction

Jean Ferand Armand Lacrampe, hailing from Le Mesnil-Esnard, France, is a notable inventor recognized for his contributions to the field of pharmaceuticals. With a focus on innovative solutions to complex biological interactions, Lacrampe has made significant strides in enhancing therapeutic options.

Latest Patents

Lacrampe holds a patent for "Inhibitors of the interaction between MDM2 and P53." This groundbreaking invention provides compounds of formula (I) that function as inhibitors of the p53-MDM2 interaction, offering potential for new pharmaceutical compositions. The defined meanings for various parameters in the patent underscore the specificity and applicability of the compounds developed.

Career Highlights

Currently, Lacrampe is a valuable member of Janssen Pharmaceutica NV, where his pioneering work contributes to the company's mission of addressing unmet medical needs. With one patent to his credit, Lacrampe is on the cutting edge of research and development within the pharmaceutical industry.

Collaborations

Throughout his career, Lacrampe has collaborated with esteemed colleagues, including Christophe Meyer and Yannick Aimè Eddy Ligny. These partnerships highlight the importance of teamwork in driving innovation and advancing pharmaceutical research.

Conclusion

Jean Ferand Armand Lacrampe exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of MDM2 and P53 interactions, hold promise for future therapeutic advancements. As he continues his work at Janssen Pharmaceutica NV, Lacrampe remains a vital figure in the ongoing quest for effective medical solutions.